Zhejiang Garden Biopharmaceutical Co (SZSE:300401) ROCE % : 11.33% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Garden Biopharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Zhejiang Garden Biopharmaceutical Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 11.33%.

Zhejiang Garden Biopharmaceutical Co ROCE % Historical Data

The historical data trend for Zhejiang Garden Biopharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Garden Biopharmaceutical Co ROCE % Chart

Zhejiang Garden Biopharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

24.47

12.50

21.35

17.02

7.32

Zhejiang Garden Biopharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															7.77	8.65	4.29	5.25	11.33

Zhejiang Garden Biopharmaceutical Co ROCE % Calculation

Zhejiang Garden Biopharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	249.46	/	( ( (4131.86 - 1309.057)	+	(5260.592 - 1263.671) )	/ 2 )
	=	249.46	/	( (2822.803	+	3996.921)	/ 2 )
	=	249.46	/	3409.862
	=	7.32 %

Zhejiang Garden Biopharmaceutical Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	459.344	/	( ( (5260.592 - 1263.671)	+	(5520.999 - 1406.824) )	/ 2 )
	=	459.344	/	( ( 3996.921	+	4114.175 )	/ 2 )
	=	459.344	/	4055.548
	=	11.33 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Zhejiang Garden Biopharmaceutical Co (SZSE:300401) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Zhejiang Garden Biopharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Zhejiang Garden Biopharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Garden Biopharmaceutical Co (SZSE:300401) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Garden Biopharmaceutical Co Ltd (SZSE:300401) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No. 166, Street 20, Economic & Technological Development Zone, Zhejiang, Hangzhou, CHN, 310018

Website

http://www.hybiotech.com

Zhejiang Garden Biopharmaceutical Co Ltd is a China-based company. Along with its subsidiaries, the firm is engaged in the pharmaceutical manufacturing. Its business activities include research, production, and sale of vitamin D3, cholesterol, and lanolin products. Its products include lanolin alcohol pharma, lanolin alcohol cosmetic, cholesterol BP, vitamin D3 oil feed grade, vitamin D3 500 feed grade CWS, lanolin alcohol EP 200, among others.

Executives

Shao Xu Jun	Director
Liu Xiao Ping	Executives
Shao Qin Xiang	Director
Shao Jun Fang	Director
Liu Jian Gang	Directors, executives
Qian Guo Ping	Executives
Zhu Jian Xing	Supervisors
Yu Quan Heng	Directors, executives, directors
Ma Huan Zheng	Directors, executives
Li Hui Ying	Supervisors
Ma Wen De	Director
Chen Yi	Executives
Gu Yi Kang	Independent director

Zhejiang Garden Biopharmaceutical Co (SZSE:300401) Headlines

No Headlines